Stock screenerAll disclosures →
EDGAR →
QTTB
Conviction 76HealthcareScan · Mon, Aug 10, 2026QTTB$15.65+0.32%
ResistanceSupportVol 14Insider buy8
Vol MA14 493.52K
May 11May 28Jun 16Jul 6Jul 23Aug 10
WSB mentions · 24h changelatest +100.00%· 2 mentions
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price15.65
Change+0.32%
Gap+1.15%
Rel volume0.07×
Avg volume1.17M
Avg $ vol18.61M
SMA 2015.63
SMA 5013.98
SMA 2006.84
Price vs 50+11.97%
Price vs 200+128.89%
MA stackbullish
50/200 cross—
Supertrendup · 12.38
RSI (14)54
MACD hist-0.12
MACD cross—
Stoch %K / %D49 / 58
ADX (14)35
+DI / −DI26 / 14
RSI divergence—
MACD divergence—
ATR %+9.56%
ADR %9.20%
52w high21.38
52w low1.63
From 52w high-26.80%
Above 52w low+860.12%
New 52w highNo
SqueezeOn · 1d
Bollinger width20.03%
%B0.51
Donchian pos16.10%
Donchian high23.57
Donchian low14.13
AVWAP (52w high)16.44
vs AVWAP high-4.79%
AVWAP (52w low)7.77
vs AVWAP low+101.50%
OBV trendDown
Chaikin MF (20)-0.44
Today vs 20d0.07×
Avg vol (14d)493.51K
Avg vol (20d)1.17M
Avg $ vol (20d)18.61M
Market cap465.89M
RS 3m (vs SPY)+181.07%
RS 6m (vs SPY)+288.99%
RS line new highNo
Trend template7/8
Technical rank75.4
1 week+3.20%
1 month+39.61%
3 months+191.43%
6 months+269.10%
1 year+774.30%
YTD+354.94%
P/E15.62
P/B4.40
P/S403.02
P/FCF-13.89
EPS2.42
Div yield—
ROE28.16%
ROA25.74%
Debt/Eq—
Current20.30
EV/EBITDA—
Gross margin—
Net margin—
Rev growth-63.97%
EPS growth162.47%
Price target42.75
Target upside173.16%
Analyst ratingBuy
Institutional29.18%
Ent. value359.62M
Revenue0
Net income-8.95M
Gross profit—
Free cash flow-33.54M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out16.96M
Employees22
ListedTue, Mar 26, 2024
Free float5.55M
Float %38.0%
Short interest2.26M
Days to cover0.6d
Short volume47.8%
Squeeze score48 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.44 vs −$0.53
Last surprise+17.0% beat
Setup gradeA
Conviction76 / 100
Pattern quality—
Tech rank75.4 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.26
Support10.68
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in QTTB
No recent disclosed trades by Congress in QTTB. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in QTTB · 8 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
OrbiMed Genesis GP LLC Director · Common Stock · 2026-05-28 | Buy | 625K | $5.0M | 2026-05-28 | 2026-06-01 |
ORBIMED ADVISORS LLC Director · Common Stock · 2026-05-28 | Buy | 625K | $5.0M | 2026-05-28 | 2026-06-01 |
OrbiMed Capital GP VII LLC Director · Common Stock · 2026-05-28 | Buy | 625K | $5.0M | 2026-05-28 | 2026-06-01 |
OrbiMed Genesis GP LLC Director · Common Stock · 2026-05-28 | Buy | 1.25M | $10M | 2026-05-28 | 2026-06-01 |
ORBIMED ADVISORS LLC Director · Common Stock · 2026-05-28 | Buy | 1.25M | $10M | 2026-05-28 | 2026-06-01 |
Xu Diyong Director · Common Stock · 2026-05-28 | Buy | 1.25M | $10M | 2026-05-28 | 2026-06-01 |
OrbiMed Capital GP VII LLC Director · Common Stock · 2026-05-28 | Buy | 1.25M | $10M | 2026-05-28 | 2026-06-01 |
Xu Diyong Director · Common Stock · 2026-05-28 | Buy | 625K | $5.0M | 2026-05-28 | 2026-06-01 |
SEC filings
EDGAR filings in QTTB · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.